Renal Cancer - Results from #5180

Optimum outcome achievement in partial nephrectomy for T1 renal masses: a contemporary analysis of open and robot-assisted cases. May 4, 2017

Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma May 3, 2017

Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases May 3, 2017

The utility of axial abdominal imaging after partial nephrectomy for T1 renal cell carcinoma surveillance May 2, 2017

Clear cell sarcoma of kidney involving a horseshoe kidney and harboring EGFR internal tandem duplication May 2, 2017

Spotlight on nivolumab in the treatment of renal cell carcinoma: design, development, and place in therapy May 1, 2017

Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate May 1, 2017

Trends in the surgical management of Stage 1 Renal Cell Carcinoma: findings from a population-based study April 30, 2017

Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinoma April 30, 2017

Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study April 28, 2017

Bioresponsive Polyoxometalate Cluster for Redox-Activated Photoacoustic Imaging-Guided Photothermal Cancer Therapy April 28, 2017

Clinical efficacy of cabozantinib in two pediatric patients with recurrent renal cell carcinoma April 28, 2017

Perioperative epidural analgesia is not associated with increased survival from renal cell cancer, but overall survival may be improved: a retrospective chart review April 27, 2017

[Clinical and pathological prognostic factors for the long-term survival of patients with pT1 renal cell carcinoma]. April 26, 2017

Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications. April 26, 2017

Real-world experience of the feasibility and tolerability of the 2/1 dosing schedule with sunitinib in the treatment of patients with advanced renal cell carcinoma in Australia April 25, 2017

[The application value of contrast-enhanced ultrasound in the surgery of renal masses] April 25, 2017

The world of targeted therapies in kidney cancers: pitfalls, tips and tricks April 25, 2017

Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications. April 25, 2017

Profiling microRNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma April 24, 2017

Page 260 of 456